Cargando…

Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide

Ginsenosides from ginseng are used as a therapeutic agent for various diseases. They enhance the immunomodulatory effect in cyclophosphamide (CP)-treated tumor disease. The structural characteristics of steroidal saponins are mainly divided into protopanaxadiol-type saponin (PDS) and protopanaxatrio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, He, Zhang, Lancao, Yang, Chunhui, Zhang, Yuyao, Li, Jing, Zhang, Xu, Chen, Jinjin, Huang, Baotai, Zhao, Daqing, Li, Xiangyan, Zhang, Wei, Qi, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011104/
https://www.ncbi.nlm.nih.gov/pubmed/35431938
http://dx.doi.org/10.3389/fphar.2022.845034
_version_ 1784687614232625152
author Zhang, He
Zhang, Lancao
Yang, Chunhui
Zhang, Yuyao
Li, Jing
Zhang, Xu
Chen, Jinjin
Huang, Baotai
Zhao, Daqing
Li, Xiangyan
Zhang, Wei
Qi, Bin
author_facet Zhang, He
Zhang, Lancao
Yang, Chunhui
Zhang, Yuyao
Li, Jing
Zhang, Xu
Chen, Jinjin
Huang, Baotai
Zhao, Daqing
Li, Xiangyan
Zhang, Wei
Qi, Bin
author_sort Zhang, He
collection PubMed
description Ginsenosides from ginseng are used as a therapeutic agent for various diseases. They enhance the immunomodulatory effect in cyclophosphamide (CP)-treated tumor disease. The structural characteristics of steroidal saponins are mainly divided into protopanaxadiol-type saponin (PDS) and protopanaxatriol-type saponin (PTS). At present, few researchers have studied which kind of saponin plays a more important role, thus, we compared the prevention effect of PDS and PTS on myelosuppression mice induced by CP. The components and contents of saponin and monosaccharide were analyzed by using ultra high performance liquid chromatography-charged aerosol detector (UPLC-CAD) and reversed phase-high performance liquid chromatography (RP-HPLC), respectively. Thirty-two mice were randomly divided into four groups, including control, model (CP), CP+PDS, and CP+PTS. The mice were orally administered with PDS or PTS for 28 days and then injected with CP saline solution on 25, 26, 27, and 28 days at a dose of 50 mg × kg(−1). After the end of modeling, the whole blood of mice from the ophthalmic venous plexus was collected to detect routine blood tests, inflammatory cytokines, and hematopoiesis-related cytokines. Cell cycle and the apoptosis of bone marrow in the right femur were detected. The spleen and thymus were used to calculate the organ index and histological examination, and splenocytes were used to detect the percentage of CD4(+) and CD25(+) T cells. In the saponins analysis, PDS mainly included the Rb1, Rc, Rb2, and Rd of protopanaxadiol-type ginsenosides (accounted for 91.64%), and PTS mainly included the Re, Rg1, and Rf of protopanaxatriol-type ginsenosides (accounted for 75.46%). The animal results showed that both PDS and PTS improved the most indicators of myelosuppression mice induced by CP, including increased weight, blood cell numbers, hematopoiesis-related cytokines, and inflammatory cytokines; promoted the cell cycle of bone marrow and inhibited the apoptosis of bone marrow; elevated the spleen and thymus indexes and CD4(+) count of splenocytes. The prevention effect of PDS was better than PTS in some indicators, such as red blood cells, hemoglobin, interleukin (IL)-1β, IL-4, IL-10, tumor necrosis factor-α, CD4(+), and thymus index. These results suggest both PDS and PTS can prevent myelosuppression of mice induced by CP. Meanwhile, PDS and its metabolite showed higher bioavailability and bioactivity compared with PTS.
format Online
Article
Text
id pubmed-9011104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90111042022-04-16 Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide Zhang, He Zhang, Lancao Yang, Chunhui Zhang, Yuyao Li, Jing Zhang, Xu Chen, Jinjin Huang, Baotai Zhao, Daqing Li, Xiangyan Zhang, Wei Qi, Bin Front Pharmacol Pharmacology Ginsenosides from ginseng are used as a therapeutic agent for various diseases. They enhance the immunomodulatory effect in cyclophosphamide (CP)-treated tumor disease. The structural characteristics of steroidal saponins are mainly divided into protopanaxadiol-type saponin (PDS) and protopanaxatriol-type saponin (PTS). At present, few researchers have studied which kind of saponin plays a more important role, thus, we compared the prevention effect of PDS and PTS on myelosuppression mice induced by CP. The components and contents of saponin and monosaccharide were analyzed by using ultra high performance liquid chromatography-charged aerosol detector (UPLC-CAD) and reversed phase-high performance liquid chromatography (RP-HPLC), respectively. Thirty-two mice were randomly divided into four groups, including control, model (CP), CP+PDS, and CP+PTS. The mice were orally administered with PDS or PTS for 28 days and then injected with CP saline solution on 25, 26, 27, and 28 days at a dose of 50 mg × kg(−1). After the end of modeling, the whole blood of mice from the ophthalmic venous plexus was collected to detect routine blood tests, inflammatory cytokines, and hematopoiesis-related cytokines. Cell cycle and the apoptosis of bone marrow in the right femur were detected. The spleen and thymus were used to calculate the organ index and histological examination, and splenocytes were used to detect the percentage of CD4(+) and CD25(+) T cells. In the saponins analysis, PDS mainly included the Rb1, Rc, Rb2, and Rd of protopanaxadiol-type ginsenosides (accounted for 91.64%), and PTS mainly included the Re, Rg1, and Rf of protopanaxatriol-type ginsenosides (accounted for 75.46%). The animal results showed that both PDS and PTS improved the most indicators of myelosuppression mice induced by CP, including increased weight, blood cell numbers, hematopoiesis-related cytokines, and inflammatory cytokines; promoted the cell cycle of bone marrow and inhibited the apoptosis of bone marrow; elevated the spleen and thymus indexes and CD4(+) count of splenocytes. The prevention effect of PDS was better than PTS in some indicators, such as red blood cells, hemoglobin, interleukin (IL)-1β, IL-4, IL-10, tumor necrosis factor-α, CD4(+), and thymus index. These results suggest both PDS and PTS can prevent myelosuppression of mice induced by CP. Meanwhile, PDS and its metabolite showed higher bioavailability and bioactivity compared with PTS. Frontiers Media S.A. 2022-04-01 /pmc/articles/PMC9011104/ /pubmed/35431938 http://dx.doi.org/10.3389/fphar.2022.845034 Text en Copyright © 2022 Zhang, Zhang, Yang, Zhang, Li, Zhang, Chen, Huang, Zhao, Li, Zhang and Qi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, He
Zhang, Lancao
Yang, Chunhui
Zhang, Yuyao
Li, Jing
Zhang, Xu
Chen, Jinjin
Huang, Baotai
Zhao, Daqing
Li, Xiangyan
Zhang, Wei
Qi, Bin
Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title_full Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title_fullStr Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title_full_unstemmed Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title_short Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide
title_sort prevention effect of protopanaxadiol-type saponins saponins and protopanaxatriol-type saponins on myelosuppression mice induced by cyclophosphamide
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011104/
https://www.ncbi.nlm.nih.gov/pubmed/35431938
http://dx.doi.org/10.3389/fphar.2022.845034
work_keys_str_mv AT zhanghe preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT zhanglancao preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT yangchunhui preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT zhangyuyao preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT lijing preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT zhangxu preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT chenjinjin preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT huangbaotai preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT zhaodaqing preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT lixiangyan preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT zhangwei preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide
AT qibin preventioneffectofprotopanaxadioltypesaponinssaponinsandprotopanaxatrioltypesaponinsonmyelosuppressionmiceinducedbycyclophosphamide